Antineoplastic agents
Clinical trials for Antineoplastic agents explained in plain language.
Never miss a new study
Get alerted when new Antineoplastic agents trials appear
Sign up with your email to follow new studies for Antineoplastic agents, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can radiation plus two immunotherapies shrink Hard-to-Treat tumors?
Disease control OngoingThis early-stage trial is testing whether combining targeted radiation (SBRT) with two immunotherapy drugs—nivolumab and an experimental anti-IL-8 antibody—is safe and potentially effective for people with advanced solid tumors or melanoma that have stopped responding to standard…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase 1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a targeted drug delay prostate cancer progression?
Disease control OngoingThis phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy (abiraterone plus prednisone) can delay cancer growth in men with high-risk prostate cancer that has spread to bones or organs. Participants receive either abemaciclib or a placebo a…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC